Mylan Initiates Voluntary Nationwide Recall Of Three Lots Of Nizatidine Capsules, USP, Due To Detection Of Trace Amounts Of NDMA Impurity Found In Active Pharmaceutical Ingredient Manufactured By Solara
Benzinga Newsdesk